The first half of 2026 has introduced one of the most aggressive regulatory and reimbursement shifts the laboratory industry has seen in years. New CMS requirements, expanded FDA oversight, digital CLIA enforcement, evolving payer edits, and rapid adoption of AI-driven revenue cycle management are all arriving at once. For many labs, the financial pressure is not theoretical. It is already showing up in denial rates, delayed reimbursements, and rising operational costs.
The laboratory industry is entering a period of major operational and financial change. Recent CMS and FDA regulatory updates are beginning to reshape how laboratories manage compliance, billing, and reimbursement, and the effects are not theoretical. For many labs, increased denials, delayed reimbursements, expanded documentation requests, and tighter payer scrutiny are already showing up in the numbers.
The Importance of Patient Engagement: Why They - And You - Need It
Learn why patient engagement is a necessity and how you can master it within your practice.
Clinical laboratories are operating in a much tighter enforcement environment than they were a few years ago. The Department of Justice continues to focus on healthcare fraud, False Claims Act liability, kickback arrangements, medically unnecessary testing, and billing patterns that suggest revenue is being generated without enough compliance control behind it.
Medical Billing / RCM | Laboratory
For clinical laboratories, compliance risk is no longer confined to the legal department. It is now a core financial, operational, and enterprise risk.
Medical Billing / RCM | Laboratory
Laboratory reimbursement is back in the spotlight and the stakes are higher than ever before.
Medical Billing / RCM | Laboratory
Why Accounts Receivable are the Lifeline of Every Laboratory For most laboratories, the biggest financial challenge isn’t the number of tests performed; it’s the number of claims still sitting unpaid.
Medical Billing / RCM | Laboratory
Why Laboratory RCM Is the New Profit Center Laboratories sit at the crossroads of precision science and complex finance. Every test performed represents both a clinical outcome and a potential reimbursement challenge. Between payer policy changes, strict documentation rules, and fluctuating volumes, laboratories often find their financial health limited not by test quality, but by their billing performance.
Medical Billing / RCM | Laboratory
Why Laboratory Revenue Cycles Are Harder Than Ever For laboratories, billing and reimbursement have always been complex. But in 2026, the landscape is tougher than ever with payers tightening rules, denials rising, and the costs of managing claims climbing.